Halazepam can cause developmental toxicity according to state or federal government labeling requirements. Halazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Paxipam and Pacinone. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 31640.
Halazepam
| CAS No | 23092-17-3 |
|---|---|
| Molecular Formula | C17H12ClF3N2O |
| Molecular Weight | 352.7 g/mol |
| Synonyms | 7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Halazepam can cause developmental toxicity according to state or federal government labeling requirements. Halazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.
The listed CAS number is 23092-17-3.
The listed molecular formula is C17H12ClF3N2O.
The listed molecular weight is 352.7 g/mol.
7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one.
The source lists Paxipam and Pacinone.